EUVIMEDEUVIMED entdecken
Open Access

Differential response of MDA‑MB‑231 breast cancer and MCF10A normal breast cells to cytoskeletal disruption

Sangwoo Kwon, Se Jik Han, Kyung Sook Kim

Oncology Reports · 2023

DOI: 10.3892/or.2023.8637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2023. Verfasst von Sangwoo Kwon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleVimentinCell Line, TumorActinsCytoskeletonCell Movement

Stichwörter der Autor:innen

F‑actinbreast cancermetastatic cancertargeted therapyvimentin

Substanzen

VimentinActins

Autor:innen und Institutionen

  • Department of Biomedical Engineering, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.

Zitieren

APA

Kwon, S., Han, S. J., & Kim, K. S. (2023). Differential response of MDA‑MB‑231 breast cancer and MCF10A normal breast cells to cytoskeletal disruption. Oncology Reports. https://doi.org/10.3892/or.2023.8637

Vancouver

Kwon S, Han SJ, Kim KS. Differential response of MDA‑MB‑231 breast cancer and MCF10A normal breast cells to cytoskeletal disruption. Oncology Reports. 2023. doi:10.3892/or.2023.8637

BibTeX
@article{Kwon2023,
  author = {Kwon, Sangwoo and Han, Se Jik and Kim, Kyung Sook},
  title = {Differential response of MDA‑MB‑231 breast cancer and MCF10A normal breast cells to cytoskeletal disruption},
  journal = {Oncology Reports},
  year = {2023},
  doi = {10.3892/or.2023.8637}
}
Kostenlos starten →